Performance Zone, a gym in Morehead City, offers a program aimed at improving the lives of individuals battling Parkinson's ...

Recent research suggests a gut-brain connection in Parkinson’s Disease, impacting diagnosis, progression, and treatment ...

"For too long, the Parkinson's community has had limited treatment options for advanced disease," Robert Hauser, MD, MBA, of ...

With two complete response letters in the rearview mirror, Abbvie Inc.’s Vyalev (foscarbidopa/foslevodopa) has been approved by the U.S. FDA for treating Parkinson’s disease. The drug is the first ...

The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...

A patient who received a new infusion therapy treatment for Parkinson’s disease showed progress after just two days, Sherwood Forest Hospitals said.

New OU program allows graduates to bypass FAA air traffic control academy ...

Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor ...

Annovis faces financial challenges and questionable efficacy in Alzheimer's and Parkinson's trials, risking poor stock ...

After two previous failed attempts with the FDA, AbbVie now has one more offering in its lineup — a critical step as it ...

Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired ...

Former BBC journalist Rory Cellan-Jones reveals the rollercoaster of life of Sophie from frightened rescue pup toloving ...